Lin Ben - Net Worth and Insider Trading
Lin Ben Net Worth
The estimated net worth of Lin Ben is at least $104 Million dollars as of 2024-12-15. Lin Ben is the Director of Tibet Rhodiola Pharmaceutical Holding Co and owns about 2,784,182 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) stock worth over $104 Million. Details can be seen in Lin Ben's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lin Ben has not made any transactions after 2008-01-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lin Ben
Lin Ben Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lin Ben owns 1 companies in total, including Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) .
Click here to see the complete history of Lin Ben’s form 4 insider trades.
Insider Ownership Summary of Lin Ben
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | Director |
Lin Ben Latest Holdings Summary
Lin Ben currently owns a total of 1 stock. Lin Ben owns 2,784,182 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) as of January 25, 2008, with a value of $104 Million.
Latest Holdings of Lin Ben
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600211 | Tibet Rhodiola Pharmaceutical Holding Co | 2008-01-25 | 2,784,182 | 37.48 | 104,351,141 |
Holding Weightings of Lin Ben
Lin Ben Form 4 Trading Tracker
According to the SEC Form 4 filings, Lin Ben has made a total of 0 transactions in Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) over the past 5 years. The most-recent trade in Tibet Rhodiola Pharmaceutical Holding Co is the sale of 2,784,182 shares on January 25, 2008, which brought Lin Ben around $8 Million.
Insider Trading History of Lin Ben
- 1
Lin Ben Trading Performance
GuruFocus tracks the stock performance after each of Lin Ben's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lin Ben is -40%. GuruFocus also compares Lin Ben's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lin Ben within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lin Ben's insider trading performs compared to the benchmark.
Performance of Lin Ben
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 2.75 | | | | | |
Lin Ben Ownership Network
Ownership Network List of Lin Ben
Ownership Network Relation of Lin Ben
Lin Ben Owned Company Details
What does Tibet Rhodiola Pharmaceutical Holding Co do?
Who are the key executives at Tibet Rhodiola Pharmaceutical Holding Co?
Lin Ben is the Director of Tibet Rhodiola Pharmaceutical Holding Co. Other key executives at Tibet Rhodiola Pharmaceutical Holding Co include senior management Wang Bao Ming , senior management Cao Shu Zhen , and Supervisors Ren Bei Chen .
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tibet Rhodiola Pharmaceutical Holding Co Insider Transactions
Lin Ben Mailing Address
Above is the net worth, insider trading, and ownership report for Lin Ben. Currently GuruFocus does not have mailing address information for Lin Ben.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
